Literature DB >> 24760374

Anxiolytic effects of oxytocin in cue-induced cocaine seeking behavior in rats.

Amarilys Morales-Rivera1, Mayté M Hernández-Burgos, Arlene Martínez-Rivera, Jeremy Pérez-Colón, Raymond Rivera, Janitza Montalvo, Enrique Rodríguez-Borrero, Carmen S Maldonado-Vlaar.   

Abstract

RATIONALE: Oxytocin (OT) is a neuropeptide previously related to reward, learning, memory, and stress, events associated with cocaine addiction. OT has shown anxiolytic properties in different animal models of anxiety. Moreover, previous data have demonstrated an increase in mRNA OT levels within the nucleus accumbens (NAc) following acute and chronic cocaine exposure in rats. Therefore, OT might play a modulatory role in the rewarding properties of cocaine.
OBJECTIVES: The present set of experiments aims to examine the role of OT on environmentally elicited cocaine-seeking behavior and whether OT could reduce anxiety associated with this behavior.
METHODS: Separate groups of rats were trained in a cue-elicited cocaine-seeking behavior paradigm. Prior to the reinstatement phase, animals received microinfusions of artificial cerebrospinal fluid (aCSF), OT, OT agonist (TgOT), or OT antagonist (OTA) within the intracerebral ventricular intracerebroventricular (ICV) system. To test OT anxiolytic effects in reinstatement behavior, separate groups of animals were trained in a cue-elicited cocaine-seeking behavior protocol or in a cocaine-conditioning paradigm. At the end of each behavioral training, all animals were ICV pretreated with aCSF or OT, and then exposed to an elevated plus maze.
RESULTS: Results showed that OT and TgOT pretreatment significantly reduced reinstatement of cocaine-seeking behavior. Most significantly, OT treatment reduced the anxiety triggered by cue-induced reinstatement conditions and cocaine-paired conditioned locomotion.
CONCLUSIONS: The present study demonstrates for the first time that OT actions within the brain mediate the anxiety response triggered by cues previously paired with cocaine intake.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24760374     DOI: 10.1007/s00213-014-3553-y

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  42 in total

1.  Evoked axonal oxytocin release in the central amygdala attenuates fear response.

Authors:  H Sophie Knobloch; Alexandre Charlet; Lena C Hoffmann; Marina Eliava; Sergey Khrulev; Ali H Cetin; Pavel Osten; Martin K Schwarz; Peter H Seeburg; Ron Stoop; Valery Grinevich
Journal:  Neuron       Date:  2012-02-09       Impact factor: 17.173

Review 2.  Discovery, development, and some uses of vasopressin and oxytocin antagonists.

Authors:  M Manning; W H Sawyer
Journal:  J Lab Clin Med       Date:  1989-12

3.  Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats.

Authors:  R J Windle; N Shanks; S L Lightman; C D Ingram
Journal:  Endocrinology       Date:  1997-07       Impact factor: 4.736

4.  Oxytocin-induced excitation of neurones in the rat central and medial amygdaloid nuclei.

Authors:  M G Terenzi; C D Ingram
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

Review 5.  Cocaine and the club drugs.

Authors:  Samuel Demaria; Julia L Weinkauf
Journal:  Int Anesthesiol Clin       Date:  2011

Review 6.  Oxytocin: who needs it?

Authors:  T R Insel; B S Gingrich; L J Young
Journal:  Prog Brain Res       Date:  2001       Impact factor: 2.453

7.  An anxiolytic action of oxytocin is enhanced by estrogen in the mouse.

Authors:  M M McCarthy; C H McDonald; P J Brooks; D Goldman
Journal:  Physiol Behav       Date:  1996-11

Review 8.  Oxytocin and addiction: a review.

Authors:  G L Kovács; Z Sarnyai; G Szabó
Journal:  Psychoneuroendocrinology       Date:  1998-11       Impact factor: 4.905

Review 9.  Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents.

Authors:  Maurice Manning; Stoytcho Stoev; Bice Chini; Thierry Durroux; Bernard Mouillac; Gilles Guillon
Journal:  Prog Brain Res       Date:  2008       Impact factor: 2.453

10.  Oxytocin attenuates stress-induced c-fos mRNA expression in specific forebrain regions associated with modulation of hypothalamo-pituitary-adrenal activity.

Authors:  Richard J Windle; Yvonne M Kershaw; Nola Shanks; Susan A Wood; Stafford L Lightman; Colin D Ingram
Journal:  J Neurosci       Date:  2004-03-24       Impact factor: 6.167

View more
  16 in total

1.  A two-week pilot study of intranasal oxytocin for cocaine-dependent individuals receiving methadone maintenance treatment for opioid use disorder.

Authors:  Christopher S Stauffer; Vivek Musinipally; Angela Suen; Kara L Lynch; Brad Shapiro; Joshua D Woolley
Journal:  Addict Res Theory       Date:  2016-05-25

Review 2.  Targeting the Oxytocin System to Treat Addictive Disorders: Rationale and Progress to Date.

Authors:  Mary R Lee; Matthew C H Rohn; Gianluigi Tanda; Lorenzo Leggio
Journal:  CNS Drugs       Date:  2016-02       Impact factor: 5.749

Review 3.  Oxytocin for the treatment of drug and alcohol use disorders.

Authors:  Mary R Lee; Elise M Weerts
Journal:  Behav Pharmacol       Date:  2016-12       Impact factor: 2.293

4.  Neuroprotective effects of melatonin administration against chronic immobilization stress in rats.

Authors:  Asmaa Ms Gomaa; Heba M Galal; Amal T Abou-Elgait
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2017-04-15

5.  Oxytocin Acts in Nucleus Accumbens to Attenuate Methamphetamine Seeking and Demand.

Authors:  Brittney M Cox; Brandon S Bentzley; Helaina Regen-Tuero; Ronald E See; Carmela M Reichel; Gary Aston-Jones
Journal:  Biol Psychiatry       Date:  2016-12-01       Impact factor: 13.382

Review 6.  Neural mechanisms underlying incubation of methamphetamine craving: A mini-review.

Authors:  Rachel D Altshuler; Hongyu Lin; Xuan Li
Journal:  Pharmacol Biochem Behav       Date:  2020-10-23       Impact factor: 3.533

7.  Oxytocin decreases cocaine taking, cocaine seeking, and locomotor activity in female rats.

Authors:  Kah-Chung Leong; Luyi Zhou; Shannon M Ghee; Ronald E See; Carmela M Reichel
Journal:  Exp Clin Psychopharmacol       Date:  2016-02       Impact factor: 3.157

8.  Paternal Cocaine in Mice Alters Social Behavior and Brain Oxytocin Receptor Density in First Generation Offspring.

Authors:  Alexandra M Yaw; J David Glass; Rebecca A Prosser; Heather K Caldwell
Journal:  Neuroscience       Date:  2022-01-19       Impact factor: 3.590

Review 9.  Oxytocin and Addiction: Potential Glutamatergic Mechanisms.

Authors:  Megana Sundar; Devon Patel; Zachary Young; Kah-Chung Leong
Journal:  Int J Mol Sci       Date:  2021-02-27       Impact factor: 5.923

10.  Oxytocin attenuates neural response to emotional faces in social drinkers: an fMRI study.

Authors:  Patrick Bach; Anne Koopmann; Jan Malte Bumb; Sina Zimmermann; Sina Bühler; Iris Reinhard; Stephanie H Witt; Marcella Rietschel; Sabine Vollstädt-Klein; Falk Kiefer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-02-19       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.